David Krenn

David Krenn is an experienced financial executive currently serving as the Chief Financial Officer at HistoSonics, Inc. since April 2022. Previously, Krenn held the CFO position at Marsh & McLennan Agency - Upper Midwest from December 2016 to April 2022, and at ValenTx, Inc. from July 2014 to November 2016. Krenn's career includes key financial roles such as Director of Financial Planning & Analysis at CryoLife, Inc., Vice President of Finance at Hemosphere, Inc., and various finance positions at Medtronic, ATS Medical, and Boston Scientific. Krenn began the professional journey at KPMG as a Senior Associate after completing a degree at Saint John's University from 1997 to 2001.